HomeKYMR • NASDAQ
add
Kymera Therapeutics Inc
Previous close
$36.30
Day range
$36.06 - $38.21
Year range
$9.60 - $45.31
Market cap
2.29B USD
Avg Volume
505.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 10.29M | 8.67% |
Operating expense | 63.19M | 402.93% |
Net income | -48.56M | -18.64% |
Net profit margin | -472.02 | -9.17% |
Earnings per share | -0.62 | 11.92% |
EBITDA | -51.44M | -15.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 520.54M | 31.16% |
Total assets | 868.25M | 41.43% |
Total liabilities | 157.05M | 3.39% |
Total equity | 711.20M | — |
Shares outstanding | 61.36M | — |
Price to book | 3.13 | — |
Return on assets | -18.32% | — |
Return on capital | -20.70% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -48.56M | -18.64% |
Cash from operations | -39.59M | 9.95% |
Cash from investing | -330.61M | -1,444.81% |
Cash from financing | 353.76M | 30,422.52% |
Net change in cash | -16.44M | 9.78% |
Free cash flow | -58.42M | -72.40% |
About
Founded
2015
Headquarters
Website
Employees
186